Nuclear Medicine: Page 290

IBA partners with Advion BioSystems

By AuntMinnie.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) has become a worldwide, nonexclusive sales agent for the Advion NanoTek microfluidic synthesis system from Advion BioSystems of Ithaca, NY.

August 9, 2009

FDA panel to review GE DaTscan agent

By AuntMinnie.com staff writers

A U.S. Food and Drug Administration advisory panel will meet on August 11 to discuss GE Healthcare's new drug application for DaTscan (ioflupane iodine-123 injection).

August 9, 2009

PETNet opens new facility in Australia

By AuntMinnie.com staff writers

PETNet Solutions, a subsidiary of Siemens Healthcare, has opened a new radiopharmaceutical production facility in Sydney, Australia.

August 5, 2009

Eckert & Ziegler continues record course

By AuntMinnie.com staff writers

Fueled by sales growth in its Nuclear Imaging segment, radiation therapy and radiopharmaceutical developer Eckert & Ziegler Strahlen-und Medizintechnik set new sales records at the six-month mark of 2009.

August 3, 2009

Cardinal Health acquires Biotech

By AuntMinnie.com staff writers

Cardinal Health has acquired Biotech, a PET cyclotron and nuclear pharmacies firm in the southwestern U.S.

August 2, 2009

FDG-PET best for early detection of neuroblastoma

By Wayne Forrest

FDG-PET shows "superior" ability to detect early-stage neuroblastoma, whereas scintigraphy with iodine-123 metaiodobenzylguanidine (I-123 MIBG) can be beneficial in detecting the pediatric disease in more progressed stages, according to a study published in the August issue of the Journal of Nuclear Medicine.

August 2, 2009

MDS offers plan to fix Maple reactors

By AuntMinnie.com staff writers

MDS Nordion is again urging Atomic Energy of Canada to complete and bring online the two Maple nuclear reactors to help solve the medical isotope shortage.

July 30, 2009

Dual-source CTA turns in mixed results for coronary stenoses

By Wayne Forrest

Dual-source CT angiography (CTA) achieves a high negative predictive value in excluding coronary artery stenoses in patients with stable coronary artery disease, but the modality is "very limited" in its ability to predict the presence of ischemia, according to a study by German researchers.

July 29, 2009

Coalition urges Congress to act on Mo-99

By AuntMinnie.com staff writers

Nine professional healthcare and related organizations are urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99).

July 28, 2009

Neoprobe nets $3.5 million

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe will receive $3.5 million after an exercise of warrants by investment firm Platinum-Montaur Life Sciences.

July 27, 2009

Just how bad is contrast nephropathy? And, AAPM news; Congress tackles moly crisis

By Brian Casey

July 27, 2009

Markey bill would fund U.S. isotope production

By Wayne Forrest

A bill introduced into the U.S. House of Representatives this month will authorize the U.S. Department of Energy to spend $163 million over the next five years toward the eventual production of molybdenum-99 in the U.S.

July 27, 2009

Previous Page

Page 290 of 440

Next Page